Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.
The linac devices market has experienced considerable growth in recent years, driven by advancements in cancer treatment and expanding healthcare infrastructure worldwide. This sector is primed for further expansion as new technologies and increasing demand for precision oncology continue to shape its future landscape. Let’s delve into the current market size, key growth drivers, leading players, emerging trends, and regional dynamics shaping this industry.
Steady Expansion in the Linac Devices Market Size and Value
The linac devices market is on a robust upward trajectory. It is projected to grow from $5.48 billion in 2025 to $5.96 billion in 2026, reflecting a compound annual growth rate (CAGR) of 8.9%. This upward movement in the past years has been largely fueled by the growth of cancer treatment facilities, a rise in cancer incidence worldwide, adoption of more advanced radiotherapy techniques, greater availability of oncology specialists, and improvements in radiation delivery precision. Looking ahead, the market is forecast to expand further, reaching $8.48 billion by 2030 with an even higher CAGR of 9.2%. Factors contributing to this growth include increasing investments in precision oncology, the growing demand for personalized cancer therapies, innovation in AI-driven radiotherapy planning, broader access to radiotherapy in emerging regions, and greater use of compact linac systems. Key trends anticipated to influence the market include wider adoption of image-guided radiation therapy, increased use of high-energy linac devices, integration of AI-based treatment planning, and the development of compact, modular linac designs focused on delivering precise radiation doses.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10626&type=smp
Cancer Prevalence as a Critical Growth Factor for the Linac Devices Market
The rising incidence of cancer is a primary force accelerating the demand for linac devices. Cancer prevalence refers to the total number of people living with cancer at a given time, both newly diagnosed and previously treated. This increase is linked to lifestyle-related risk factors such as poor diet, tobacco use, alcohol consumption, and exposure to environmental pollutants, all contributing to a higher risk of various cancers. LINAC devices play an essential role in cancer management by delivering targeted, high-energy radiation beams that focus on tumors while sparing surrounding healthy tissues. These devices improve treatment accuracy, patient outcomes, and enable advanced radiotherapy methods. For example, in February 2025, Cancer Australia reported 4,641 new cases of pancreatic cancer in 2024, split between 2,414 males and 2,227 females, illustrating the ongoing demand for effective treatment options and driving market growth.
Technological Advancements and Innovation Impacting the Linac Devices Market
Leading companies in the linac devices industry are continually launching innovative products to maintain their competitive edge. A notable example is the incorporation of MRI-guided radiation therapy systems. In March 2023, GenesisCare Pty Ltd., a US-based provider specializing in cancer and cardiac care, introduced the ViewRay MRIdian MRI-Guided Radiation Therapy System at the Lee Health Regional Cancer Center. This system combines high-resolution MRI imaging with advanced linear accelerator technology, enabling more precise radiation delivery and potentially reducing the number of treatment sessions needed. The MRIdian system is unique as it offers diagnostic-quality MRI integrated with radiotherapy and features the MRIdian Stereotactic MRI-guided Adaptive Radiotherapy (SMART) technology, enhancing treatment personalization and effectiveness.
Access The Complete LINAC Devices Market Report:
https://www.thebusinessresearchcompany.com/report/linac-devices-global-market-report
Key Segments Defining the Linac Devices Market Landscape
This report segments the linac devices market into distinct categories to highlight growth opportunities. By product type, it is divided into High Energy and Medium Energy devices. Applications cover various cancer types such as breast, colorectal, head and neck, lung, prostate, and others. End users primarily include clinics and hospitals. Subcategories under High Energy devices include linear accelerators for radiation therapy, electron linacs, and photon linacs. Medium Energy devices are further divided into medium energy photon linacs and compact linac systems, reflecting the diversity of technologies catering to different treatment needs and settings.
Top Companies Shaping the Competitive Environment of Linac Devices
The linac devices market features a mix of established multinational corporations and specialized technology providers. Some of the leading companies include Elekta AB, Varian Medical Systems Inc, Siemens Healthineers GmbH, Hitachi Ltd, Mitsubishi Heavy Industries Ltd, Sumitomo Heavy Industries Ltd, Shinva Medical Instrument Co Ltd, Huiheng Medical Inc, IBA SA, Mevion Medical Systems Inc, ViewRay Technologies Inc, Advanced Oncotherapy PLC, RefleXion Medical Inc, ProNova Solutions LLC, Panacea Medical Technologies Pvt Ltd, Best Theratronics Ltd, P-Cure Ltd, Accuray Incorporated, CGN Dasheng Electron Accelerator Technology Co Ltd, Nordion Inc, and Theragenics Corporation. These players drive innovation, expand market reach, and influence the direction of future developments.
Regional Insights Highlight Linac Devices Market Leaders and Growth Hotspots
In 2025, North America accounted for the largest revenue share in the linac devices market, leveraging its advanced healthcare infrastructure and technology adoption. Conversely, the Asia-Pacific region is expected to be the fastest-growing market segment during the forecast period, thanks to increasing investments in healthcare, expanding cancer treatment facilities, and rising awareness about advanced radiotherapy options. The report provides a comprehensive overview of key regions including Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, offering a global perspective on market trends and growth potential.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
